BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 20528641)

  • 1. Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
    Lin CP; Hsu TJ; Tung YC; Hsiao FC; Chou SH; Lin YS; Chen SW; Chu PH
    J Am Heart Assoc; 2024 May; 13(9):e033780. PubMed ID: 38686894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving adherence with amlodipine/atorvastatin therapy: IMPACT study.
    Oliver S; Jones J; Leonard D; Crabbe A; Delkhah Y; Nesbitt S
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):598-604. PubMed ID: 21806770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin.
    Hobbs FD
    Vasc Health Risk Manag; 2007; 3(5):711-9. PubMed ID: 18078022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination.
    Aslam F; Haque A; Lee V; Foody J
    Patient Prefer Adherence; 2009 Nov; 3():61-6. PubMed ID: 19936146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of continuous traditional Chinese medicine nursing on patients with coronary heart disease.
    Lin C; Xie C; Chen M; Gao H; Zhang G
    Am J Transl Res; 2021; 13(8):8988-8996. PubMed ID: 34540010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-pill combination of amlodipine besylate and atorvastatin calcium.
    Blank R
    Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
    Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):835-43. PubMed ID: 20528641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
    Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.